No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
278 |
4. Check minimum number of eventsNone |
278 |
5. Include endpointsNone |
278 |
6. Filter based on genotype QC (FinnGen only) |
278 |
Control definitions (FinnGen only)
- Control exclude
- M13_SOFTTISSUE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M62
- Name in latin
- Diastasis musculi
Similar endpoints
↥List of similar endpoints to
Diastasis of muscle
based on the number of shared cases.
Similar with more cases:
- Disorders of muscles
- Soft tissue disorders
- Diseases of the musculoskeletal system and connective tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1432 | 834 | 588 |
| Only index persons | 1376 | 813 | 563 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.02 |
| Only index persons | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 48.12 | 41.83 | 57.15 |
| Only index persons | 48.03 | 41.56 | 57.37 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 278 | 183 | 95 |
| Unadjusted period prevalence (%) | 0.06 | 0.06 | 0.04 |
| Median age at first event (years) | 49.47 | 43.45 | 61.05 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 237
- Matched controls
- 2371
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M62.0
ICD-10 Finland
Diastasis of muscle
+∞
323.0
237
*
QBJ30
NOMESCO Finland
Correction of abdominal apron
674.1
56.0
53
*
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
21.6
38.8
58
35
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
17.0
28.6
46
33
JAG96
NOMESCO Finland
Other reconstruction of abdominal wall
253.5
23.0
23
*
N02AX02
ATC
tramadol; systemic, rectal
3.8
20.6
122
514
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.3
16.0
113
515
M79.6
ICD-10 Finland
Pain in limb
3.8
15.9
81
286
N02BE01
ATC
paracetamol; systemic, rectal
4.7
14.9
216
1622
N03AX12
ATC
gabapentin; oral
5.0
13.4
45
106
JN3AD
NOMESCO Finland
Abdominal CT examination
6.4
12.8
34
60
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.1
11.6
76
314
S18
ICPC
Laceration/cut
2.7
11.1
100
505
A02BC02
ATC
pantoprazole; systemic
2.6
10.8
154
995
M19.0
ICD-10 Finland
Primary arthrosis of other joints
6.5
10.5
27
46
M54.5
ICD-10 Finland
Low back pain
2.7
10.4
91
447
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
42.0
10.1
12
*
JAF10
NOMESCO Finland
Repair of umbilical hernia
11.4
10.0
18
17
JAG60
NOMESCO Finland
Reconstruction of abdominal wall using prosthetic material
104.0
9.5
10
*
O30.0
ICD-10 Finland
Twin pregnancy
10.2
9.4
18
19
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.1
9.2
36
99
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.4
9.0
107
611
R51.80
ICD-10 Finland
Headache
3.3
8.7
47
165
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.3
8.5
110
645
K45.8
ICD-10 Finland
Other specified abdominal hernia without obstruction or gangrene
+∞
8.4
8
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.4
8.3
24
48
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.9
8.3
53
211
Z01.8
ICD-10 Finland
Other specified special examinations
2.8
8.1
58
247
SPAT1262
SPAT
Handing over of treatment supplies
3.1
8.0
46
171
G47.3
ICD-10 Finland
Sleep apnoea
2.7
8.0
60
262
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.6
8.0
69
328
J01DB01
ATC
cefalexin; oral
2.6
7.7
199
1588
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.1
7.7
44
163
M75.1
ICD-10 Finland
Rotator cuff syndrome
3.1
7.7
44
164
N03AX16
ATC
pregabalin; oral
2.8
7.6
53
222
SPAT1249
SPAT
Treatment-related counselling outside office
2.2
7.6
106
637
L03
ICPC
Low back symptom/complaint
2.6
7.5
62
286
A02BC05
ATC
esomeprazole; systemic
2.3
7.4
93
528
J01AA02
ATC
doxycycline; systemic
2.3
7.4
183
1407
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
+∞
7.3
7
*
L57.4
ICD-10 Finland
Cutis laxa senilis
+∞
7.3
7
*
M79.1
ICD-10 Finland
Myalgia
3.6
7.3
33
103
M65.3
ICD-10 Finland
Trigger finger
16.4
7.3
11
7
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
6.4
7.2
18
30
E66.8
ICD-10 Finland
Other obesity
4.6
7.2
24
57
G56.0
ICD-10 Finland
Carpal tunnel syndrome
3.6
7.2
32
99
R03AC02
ATC
salbutamol; inhalant
2.1
7.0
126
836
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
2.9
7.0
46
184
SPAT1263
SPAT
Sampling
2.1
6.9
109
684
J01FA10
ATC
azithromycin; systemic
2.1
6.9
140
973
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.2
6.8
35
121
M79.0
ICD-10 Finland
Rheumatism, unspecified
23.3
6.7
9
*
N02AJ06
ATC
codeine and paracetamol; systemic
2.2
6.7
87
502
SPAT1153
SPAT
Removal of sutures
2.3
6.7
72
382
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
6.6
88
513
T90
ICPC
Diabetes non-insulin dependent
2.5
6.5
53
243
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.1
6.5
36
129
UJF32
NOMESCO Finland
Coloscopy
2.4
6.5
59
286
SFA10
NOMESCO Finland
Fillning on one surface of tooth
2.0
6.5
132
909
M79.7
ICD-10 Finland
Fibromyalgia
14.8
6.5
10
7
H02AB06
ATC
prednisolone; systemic
2.1
6.4
103
644
A10BA02
ATC
metformin; oral
2.3
6.4
65
333
N06AX21
ATC
duloxetine; oral
3.6
6.3
27
81
K42
ICD-10 Finland
Umbilical hernia
18.6
6.3
9
5
SPAT1310
SPAT
Counselling related to known health issue
2.2
6.3
78
436
4211
FHL
Transeptal septal resection and reconstruction
27.5
6.3
8
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.7
6.2
43
180
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
2.0
6.2
123
832
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
6.2
65
337
J01FF01
ATC
clindamycin; systemic
2.3
6.0
64
334
R01AD09
ATC
mometasone; nasal
2.0
6.0
112
740
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
120
591
2.81
15.51
3.0
2.2
u/l
56.8
56.0
0.05
109
552
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
170
1033
2.66
14.01
4.9
4.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
21
33
6.80
13.02
3.0
3.0
mmol/l
3.7
2.8
—
10
21
(1616796) Gas panel - Central venous blood
21
33
6.80
13.02
2.5
2.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
130
734
2.45
11.96
12.9
7.9
inr
1.2
1.2
0.23
53
250
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
161
1011
2.41
11.53
5.8
6.5
umol/l
10.4
11.3
0.77
150
956
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
54
202
3.08
11.18
4.1
2.8
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
177
1174
2.40
10.98
4.9
4.6
mmol/l
6.6
6.6
0.11
160
1072
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
137
837
2.26
10.02
4.6
3.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
100
546
2.30
9.48
5.0
3.6
estimate
0.0
0.0
0.50
39
210
(3035350) Ketones [Presence] in Urine by Test strip
158
1048
2.18
9.14
4.6
3.2
estimate
0.0
0.0
0.00
42
212
(3021601) Nitrite [Presence] in Urine by Test strip
158
1058
2.14
8.80
5.7
4.5
estimate
0.0
0.0
0.50
41
216
(3019550) Sodium [Moles/volume] in Serum or Plasma
266
2255
5.16
8.72
17.4
12.3
mmol/l
139.6
139.6
0.07
261
2192
(40767503) Oxygen content in Capillary blood by calculation
16
29
5.79
8.60
2.2
2.5
%
16.7
17.3
—
8
15
(3009261) Glucose [Presence] in Urine by Test strip
158
1067
2.11
8.50
4.6
3.3
estimate
0.0
0.0
0.00
42
203
(3023103) Potassium [Moles/volume] in Serum or Plasma
266
2263
5.06
8.49
17.6
12.4
mmol/l
3.9
3.9
0.15
261
2194
(3024561) Albumin [Mass/volume] in Serum or Plasma
129
808
2.11
8.47
4.8
4.6
g/l
36.1
36.2
0.03
119
756
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
212
1612
2.33
8.33
7.3
6.9
u/l
72.1
78.2
1.66
203
1512
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
223
1740
2.42
8.12
4.6
3.9
pmol/l
14.6
14.4
0.39
200
1599
(3013512) EKG study
94
529
2.17
8.07
3.7
3.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
114
693
2.09
7.99
4.5
3.3
ng/l
19.8
35.5
1.72
72
429
(3009508) Creatinine [Moles/volume] in Urine
100
585
2.11
7.71
3.2
3.0
mmol/l
8.3
8.0
0.32
86
502
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
89
498
2.16
7.70
3.0
2.0
mg/l
3.0
2.8
0.40
77
435
(40761536) Microorganisms panel - Urine sediment
46
192
2.67
7.68
5.2
3.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
12
18
6.92
7.67
1.1
1.9
%
89.4
89.2
0.04
12
18
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
83
453
2.19
7.64
3.1
3.6
ng/l
725.5
1105.1
0.92
66
383
(3007853) Bacteria identified in Skin by Aerobe culture
52
235
2.49
7.37
1.6
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
54
249
2.45
7.33
2.2
2.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
261
2238
3.72
7.23
15.6
11.4
mg/l
21.5
21.4
0.01
220
1715
(3000850) Epithelial cells [#/volume] in Urine
75
404
2.17
7.07
2.7
2.5
e6/l
6.8
7.8
0.14
69
353
(3037467) Urinalysis macro (dipstick) panel - Urine
196
1490
2.07
7.03
4.8
3.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
94
555
2.05
6.95
4.3
3.9
mg/mmol
2.9
9.2
2.38
57
367
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
76
415
2.14
6.91
2.0
1.7
pmol/l
437.5
19676964.6
0.50
63
371
(3019309) Folate [Moles/volume] in Red Blood Cells
62
313
2.26
6.83
2.0
1.7
nmol/l
1479.6
1140.4
1.44
46
240
(3001604) Monocytes [#/volume] in Blood
149
1038
1.94
6.79
4.4
5.5
e9/l
0.5
0.6
0.31
136
904
(3006315) Basophils [#/volume] in Blood
149
1042
1.93
6.68
4.4
5.5
e9/l
0.0
0.0
0.26
137
905
(3028271) Lactate [Moles/volume] in Capillary blood
12
21
5.93
6.64
1.2
2.0
mmol/l
1.9
1.6
0.45
12
21
(3013707) Erythrocyte sedimentation rate by Westergren method
200
1547
2.04
6.63
3.9
3.5
mm/h
10.1
10.5
0.19
191
1427
(3012516) Albumin [Mass/volume] in Urine
88
521
2.01
6.38
3.4
3.2
mg/l
22.0
302.3
0.98
52
354
(3022217) INR in Platelet poor plasma by Coagulation assay
45
204
2.44
6.31
14.0
18.3
inr
1.2
1.2
—
5
31
(3013115) Eosinophils [#/volume] in Blood
151
1074
1.89
6.30
4.4
5.9
e9/l
0.2
0.2
0.06
139
950
(3001122) Ferritin [Mass/volume] in Serum or Plasma
153
1108
1.85
5.88
3.2
2.7
ug/l
100.7
91.6
0.32
142
1036
(3013650) Neutrophils [#/volume] in Blood by Automated count
165
1225
1.85
5.84
5.2
9.2
e9/l
4.2
4.1
0.50
153
1070
(3019198) Lymphocytes [#/volume] in Blood
149
1072
1.84
5.84
4.5
5.5
e9/l
1.9
2.0
0.25
139
952
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
112
738
1.87
5.81
2.2
1.9
pmol/l
97.3
94.6
0.22
59
419
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
107
696
1.87
5.78
3.1
2.9
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
31
124
2.69
5.60
1.7
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
59
315
2.11
5.59
1.8
1.9
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
76
447
1.96
5.52
1.7
1.4
nmol/l
23.6
20.7
0.69
65
385
(3023368) Bacteria identified in Blood by Culture
78
463
1.95
5.52
4.3
4.0
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
131
923
1.79
5.35
4.6
7.0
mmol/l
1.2
1.2
0.60
103
785
(3044640) Blood type and Crossmatch panel - Blood
106
701
1.83
5.35
2.4
2.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
102
668
1.83
5.30
5.0
5.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
243
2089
2.30
5.19
5.4
4.5
mu/l
1.8
1.8
0.50
221
1937
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
83
517
1.86
5.02
1.7
1.9
u/l
104.2
217.4
2.29
75
483
(3026782) Osmolality of Urine
67
389
1.95
5.01
2.7
2.7
mosm/kgh2o
572.6
580.8
0.11
62
330
(3019150) Specific gravity of Urine by Refractometry
74
445
1.90
4.99
4.6
3.6
kg/l
1.0
1.0
0.70
11
64
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
43
212
2.22
4.96
8.3
5.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
131
939
1.75
4.93
4.7
5.5
%
0.7
0.7
0.06
125
883
(3018418) pH of Serum or Plasma
88
567
1.81
4.74
3.1
4.0
ph
7.4
7.4
0.96
29
107
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
49
259
2.08
4.74
2.1
2.3
%
27.5
24.4
0.52
41
229
(3030905) Polymorphonuclear cells [#/volume] in Blood
12
29
4.28
4.67
2.9
2.7
e9/l
4.7
4.6
0.07
12
29
(3041096) Erythrocytes [Presence] in Urine by Automated
96
638
1.77
4.65
4.0
2.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
29
124
2.49
4.59
1.3
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
233
2001
2.02
4.52
6.8
4.8
mmol/mol
39.5
38.7
0.76
225
1893
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
80
508
1.81
4.49
1.3
1.2
u/ml
6.0
2.2
0.47
29
141
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
12
30
4.14
4.48
2.9
3.0
%
65.8
58.4
1.21
12
30
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
116
822
1.71
4.43
4.7
6.4
mmol/l
1.2
1.2
0.93
110
760
(36304419) Bacteria [Presence] in Urine
82
528
1.78
4.38
2.9
2.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
266
2425
3.25
4.27
18.4
10.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
244
2147
2.12
4.16
5.3
3.8
mmol/l
5.9
5.8
1.36
226
1984
(3011397) Hemoglobin [Presence] in Urine by Test strip
71
444
1.80
4.16
4.4
3.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
48
264
1.99
4.16
1.3
1.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
131
973
1.66
4.10
5.0
5.5
%
2.7
2.6
0.10
125
913
(3015377) Calcium [Moles/volume] in Serum or Plasma
96
658
1.70
4.08
2.1
3.3
mmol/l
2.3
2.3
0.53
87
599
(3030467) Casts [#/volume] in Urine by Automated count
82
538
1.74
4.08
2.9
2.8
e6/l
0.1
0.4
2.88
73
396
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
18
64
2.94
4.04
2.0
1.4
nmol/l
37.9
39.9
0.14
18
64
(3021589) Normoblasts [#/volume] in Blood
131
976
1.65
4.03
9.3
8.5
e9/l
0.0
0.0
0.48
115
808
(3044889) 12 lead EKG panel
182
1479
1.67
3.93
4.4
3.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
59
356
1.83
3.87
1.5
1.2
iu/ml
37.0
26.6
0.25
18
106
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
118
864
1.64
3.84
2.5
2.2
nmol/l
73.4
73.4
0.01
109
794
(40760892) CBC W Ordered Manual Differential panel - Blood
80
532
1.71
3.76
4.5
4.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
88
601
1.68
3.74
2.9
2.9
e6/l
29.4
159.5
0.62
78
453
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
71
458
1.74
3.71
1.7
1.6
mg/l
0.9
1.1
0.39
54
352
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
31
151
2.19
3.68
2.4
2.7
ml/min/173m2
65.2
68.6
0.14
13
66
(3026008) Bacteria identified in Urine by Culture
87
595
1.67
3.67
3.0
2.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
25
112
2.35
3.60
1.6
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
100
712
1.63
3.59
3.2
3.1
u/l
29.4
30.7
0.27
90
688
(3018095) Leukocytes [#/volume] in Urine
101
721
1.63
3.59
3.1
3.3
e6/l
81.8
66.1
0.12
84
493
(3022948) Iron [Moles/volume] in Serum or Plasma
52
310
1.83
3.53
2.1
2.2
umol/l
13.8
14.2
0.14
44
289
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
8
13
6.30
3.52
1.5
1.3
mmol/l
5.2
7.2
—
8
13
(3018010) Neutrophils/100 leukocytes in Blood
131
1007
1.57
3.36
4.6
5.3
%
58.1
57.0
0.55
126
953
(3025159) Blasts/100 leukocytes in Blood
28
140
2.11
3.13
3.6
4.4
%
0.2
0.2
—
6
39
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
262
2421
2.43
3.13
11.7
8.8
u/l
25.9
25.5
0.18
255
2349
(3002179) Metamyelocytes/100 leukocytes in Blood
28
141
2.10
3.08
3.6
4.4
%
1.0
0.5
—
5
33
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
238
2136
1.79
2.97
13.1
10.2
ml/min/173m2
85.9
86.6
0.20
206
1726
(3003694) ABO and Rh group [Type] in Blood
98
722
1.55
2.95
1.6
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
34
187
1.93
2.95
1.7
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
23
109
2.21
2.94
1.2
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
38
218
1.86
2.91
1.3
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
13
47
2.85
2.86
1.8
1.3
ug/g
311.0
312.9
—
8
25
(3019060) Gas panel - Arterial blood
21
97
2.26
2.85
4.0
4.3
—
—
—
0
0
(4094501)
14
53
2.73
2.84
1.0
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
71
490
1.60
2.82
2.4
2.6
umol/l
348.4
8028.9
2.69
64
437
(3042631) Mycobacterium sp identified in Specimen
8
18
4.54
2.81
2.8
3.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
18
78
2.40
2.81
1.7
1.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
22
105
2.19
2.77
2.5
5.1
mmol/l
1.0
1.6
0.31
16
82
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
192
1647
1.54
2.75
3.4
3.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
14
5.10
2.74
1.0
1.9
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
11
37
3.05
2.72
2.4
2.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
23
114
2.11
2.65
2.5
4.8
kpa
5.1
5.1
0.21
23
106
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
33
187
1.87
2.63
1.7
1.8
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
44
273
1.73
2.61
1.4
1.3
titre
306.7
474.7
—
6
53
(3004616) Nuclear Ab [Presence] in Serum
7
15
4.76
2.61
1.6
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
13
50
2.68
2.57
2.3
2.8
mmol/l
25.2
24.8
0.13
13
39
(3024263) Appearance of Synovial fluid
5
7
7.25
2.56
1.0
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
248
2279
1.82
2.50
5.4
4.2
mmol/l
2.8
2.8
0.11
232
2132
(3009343) pH of Capillary blood
22
111
2.07
2.43
2.5
4.9
ph
7.4
7.4
—
8
13
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
40
2.82
2.40
1.5
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
182
1566
1.47
2.39
4.2
2.8
u/l
46.1
43.7
0.19
170
1498
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
46
2.68
2.39
1.5
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
27
148
1.91
2.38
3.6
4.3
%
0.0
0.1
—
5
45
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
8
6.34
2.38
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
8
6.34
2.38
1.0
1.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
244
2240
1.73
2.36
5.0
3.8
mmol/l
1.4
1.5
2.00
228
2098
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
11
41
2.75
2.30
2.5
2.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
25
136
1.92
2.26
3.5
3.6
—
—
—
0
0
(3020891) Body temperature
14
61
2.36
2.18
5.0
4.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
14
4.35
2.16
3.3
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
28
161
1.82
2.15
3.6
4.2
%
0.6
0.9
—
5
53
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
43
280
1.63
2.14
1.7
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
49
330
1.59
2.13
3.1
3.5
ng/l
156.7
516.8
0.78
31
238
(3009542) Hematocrit [Volume Fraction] of Blood
238
2185
1.62
2.12
12.8
12.2
%
39.8
39.9
0.04
153
1716
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
31
185
1.76
2.12
1.1
1.3
iu/ml
129.6
164.3
0.16
11
79
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
19
96
2.05
2.11
1.1
1.0
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
19
96
2.05
2.11
6.4
7.4
mmol/l
24.0
24.2
0.11
19
89
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
10
5.07
2.08
1.0
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
48
324
1.58
2.07
1.4
1.2
u/ml
1.1
8.0
2.12
19
133
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
15
4.06
2.05
1.5
1.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
34
211
1.70
2.03
3.6
2.6
umol/l
13.6
7.9
0.49
28
181
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
24
134
1.87
2.03
2.0
2.2
u/l
17789.0
2527.3
—
6
65
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
243
2249
1.64
2.01
5.1
3.8
mmol/l
4.7
4.7
0.05
228
2116
(3000330) Specific gravity of Urine by Test strip
19
99
1.99
1.95
2.4
3.7
—
—
—
0
0
(44813793)
5
11
4.61
1.95
1.0
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
11
4.61
1.95
1.2
1.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
24
136
1.84
1.94
2.5
2.2
ug/l
2.1
9.6
2.80
24
121
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
18
93
2.00
1.90
2.9
3.0
%
1.3
1.3
0.02
18
93
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
34
2.70
1.88
4.1
3.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
27
161
1.75
1.86
3.0
3.7
mmol/l
2.5
1.7
0.55
20
119
(3023419) Bacteria identified in Sputum by Culture
6
17
3.58
1.84
5.2
3.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
12
4.22
1.83
1.2
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
12
4.22
1.83
1.2
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
24
139
1.80
1.82
1.4
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
29
2.81
1.80
1.1
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
29
2.81
1.80
1.1
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
29
2.81
1.80
1.3
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
49
345
1.51
1.76
2.0
2.6
mmol/l
2.4
2.4
0.04
42
303
(3049717) Cytology report of Urine Cyto stain
12
54
2.28
1.76
3.2
3.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
61
2.19
1.74
1.2
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
13
61
2.19
1.74
2.0
3.7
g/l
0.3
0.2
—
8
27
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
68
513
1.43
1.73
2.5
2.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
24
2.96
1.73
1.9
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
72
549
1.42
1.73
1.9
1.6
mmol/l
1.5
1.4
0.52
57
465
(3010144) Erythrocytes [#/volume] in Synovial fluid
5
13
3.90
1.72
1.0
1.2
e6/l
18410.0
655861.0
—
5
8
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
62
2.15
1.68
1.2
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
13
62
2.15
1.68
1.2
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
16
83
1.98
1.68
1.8
1.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
26
160
1.69
1.62
3.0
3.7
kpa
5.7
5.6
0.22
26
155
(3000093) Morphology [Interpretation] in Blood Narrative
5
14
3.62
1.62
1.0
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
32
2.54
1.61
1.1
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
233
2163
1.48
1.60
4.5
3.5
mmol/l
1.4
1.2
1.44
220
2025
(3007164) IgA [Mass/volume] in Serum or Plasma
63
478
1.41
1.55
1.2
1.4
g/l
2.4
2.3
0.25
43
310
(40758558) Short blood count panel - Blood
67
514
1.40
1.55
3.4
6.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
23
139
1.71
1.54
2.4
2.6
e9/l
77.6
69.7
0.68
18
101
(3004716) Salmonella sp identified in Stool by Organism specific culture
21
124
1.75
1.52
1.4
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
14
73
1.97
1.46
1.3
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
11
52
2.16
1.46
2.4
5.8
kpa
8.7
8.6
0.11
11
47
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
16
3.16
1.44
1.8
1.4
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
16
3.16
1.44
1.2
1.9
ug/l
12.5
14.9
—
5
16
(3002173) Hemoglobin [Mass/volume] in Arterial blood
24
151
1.65
1.40
5.2
8.5
g/l
131.5
120.7
1.47
24
146
(21494755) Public health laboratory ask at order entry panel
20
317
0.60
1.38
1.3
1.3
—
—
—
0
0
(4146454)
5
17
2.97
1.36
2.2
2.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
115
976
1.30
1.35
3.1
2.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
11
54
2.08
1.34
1.5
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
107
900
1.31
1.34
2.1
2.0
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
22
137
1.66
1.34
2.9
3.2
kpa
4.6
4.8
0.22
22
132
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
16
91
1.80
1.32
2.6
2.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
24
2.53
1.31
1.5
1.7
—
—
—
0
0
(4062490)
5
18
2.81
1.29
1.2
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
216
2003
1.35
1.28
15.5
14.0
%
13.6
13.6
0.00
209
1961
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
35
2.32
1.28
1.1
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
17
100
1.75
1.26
1.8
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
36
2.26
1.25
1.6
2.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
36
2.26
1.25
2.4
2.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
43
318
1.42
1.23
1.9
2.3
e6/l
0.8
1.1
0.37
30
175
(3000764) Benzodiazepines [Presence] in Urine
17
101
1.73
1.23
1.8
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
17
101
1.73
1.23
1.8
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
19
2.66
1.22
1.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
14
79
1.81
1.19
1.1
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
17
102
1.71
1.19
1.8
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
61
482
1.34
1.18
4.8
4.2
%
20.2
21.0
0.20
29
225
(3045414) Leukocytes [Presence] in Urine
13
72
1.85
1.17
2.1
1.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
39
2.08
1.16
1.4
1.8
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
17
103
1.69
1.15
5.5
11.9
%
93.4
93.8
0.13
17
103
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
73
1.82
1.13
1.3
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
16
96
1.71
1.13
1.8
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
19
120
1.63
1.12
3.1
2.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
39
289
1.41
1.11
2.0
1.6
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
21
2.41
1.09
3.8
3.8
nmol/l
2.7
3.3
—
5
21
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
32
2.22
1.09
1.4
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
32
2.22
1.09
1.0
1.4
—
—
—
0
0
(3000492) Spirometry study
29
204
1.47
1.08
1.4
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
15
90
1.70
1.06
1.1
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
33
2.15
1.06
1.4
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
75
1.77
1.04
1.2
1.2
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
7
34
2.09
1.03
3.1
1.9
%
13.5
13.1
—
7
34
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
53
1.92
1.02
1.4
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
11
62
1.81
0.95
2.2
4.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
10
55
1.85
0.93
1.4
1.7
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
9
52
1.75
0.93
3.3
3.7
mmol/l
3.7
3.9
—
9
46
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
29
2.09
0.90
1.3
3.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
6
29
2.09
0.90
1.3
3.0
mmol/l
108.8
105.0
—
6
29
(3041354) Potassium [Moles/volume] in Venous blood
6
29
2.09
0.90
1.3
3.0
mmol/l
3.9
4.0
—
6
29
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
29
2.09
0.90
1.3
1.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
27
196
1.42
0.88
1.1
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
11
64
1.75
0.87
1.9
2.1
ug/l
5.4
0.3
0.58
11
58
(4010399)
20
137
1.50
0.87
1.7
1.3
—
—
—
0
0
(4306422)
6
31
1.96
0.85
1.0
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
6
32
1.89
0.82
1.2
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
18
123
1.50
0.80
1.1
1.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
33
1.84
0.79
1.5
1.7
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
25
0.00
0.79
0.0
1.5
—
12.4
—
0
6
(3002256) Pathology report gross observation
38
299
1.31
0.77
1.3
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
32
247
1.33
0.74
1.6
1.3
—
—
—
0
0
(4281824)
5
25
2.02
0.73
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
60
505
1.24
0.73
1.8
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
12
76
1.61
0.73
2.8
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
18
126
1.46
0.72
1.4
2.0
mg/l
2.4
2.8
0.15
12
88
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
58
487
1.24
0.72
1.8
1.7
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
26
1.94
0.71
1.0
1.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
9
59
1.54
0.69
3.4
5.4
%
1.6
1.6
—
9
54
(3028707) Methadone [Presence] in Urine by Screen method
7
44
1.61
0.65
1.0
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
29
227
1.31
0.63
1.2
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
49
1.65
0.62
1.3
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
49
1.65
0.62
1.3
1.2
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
5
30
1.68
0.61
1.0
1.7
mmol/l
6.8
7.8
—
5
18
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
20
0.00
0.60
0.0
3.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
14.5
—
962.5
—
0
20
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
19.7
—
1655.0
—
0
21
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
10
64
1.58
0.59
1.5
1.9
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
54
1.50
0.58
1.3
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
36
1.68
0.57
1.2
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
55
1.47
0.56
2.3
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
10
65
1.56
0.56
2.7
6.5
mmol/l
24.1
25.0
—
10
65
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
38
1.59
0.54
1.5
1.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
38
1.59
0.54
2.0
2.8
—
—
—
0
0
(3019225) pH of Specimen
21
162
1.32
0.51
2.9
4.8
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
13
93
1.42
0.49
1.5
1.5
miu/ml
132.9
237.3
—
5
46
(3022313) Gas panel - Capillary blood
11
76
1.47
0.49
2.5
5.6
—
—
—
0
0
(4034850)
10
68
1.49
0.47
12.4
6.8
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
28
228
1.25
0.47
6.0
4.0
%
32.5
31.9
0.14
22
147
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
13
94
1.40
0.47
1.5
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
19
148
1.30
0.45
6.1
10.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
31
1.62
0.43
1.4
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
39
335
1.19
0.41
1.9
2.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
15
0.00
0.41
0.0
2.7
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
16
0.00
0.41
0.0
3.5
—
12.3
—
0
16
(3012441) Differential panel - Pleural fluid
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
34
1.48
0.40
4.8
3.0
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.8
—
3.7
—
0
18
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
35
1.44
0.39
1.4
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
65
586
1.14
0.38
1.8
1.9
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
12
89
1.36
0.38
1.2
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
36
1.40
0.38
1.2
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
9
70
1.30
0.37
1.3
1.4
g/l
1.3
1.2
—
9
64
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
43
377
1.17
0.37
1.9
2.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
47
1.28
0.32
1.2
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
54
1.30
0.30
1.1
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
108
0.73
0.29
1.3
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
11
86
1.29
0.26
7.8
12.7
—
—
—
0
0
(1002224) Polysomnography panel
13
105
1.25
0.25
1.2
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
11
0.00
0.21
0.0
3.0
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
10
0.00
0.21
0.0
1.0
—
6.3
—
0
10
(3006598) pH of Arterial cord blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
10
0.00
0.21
0.0
1.0
—
3.9
—
0
10
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
32.4
—
0
5
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
24.5
—
0
12
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
43
1.17
0.21
1.2
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.8
—
1.0
—
0
13
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
9
111
0.80
0.20
1.3
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
9
111
0.80
0.20
1.3
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
17
197
0.85
0.20
1.3
1.4
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
14
0.00
0.20
0.0
2.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
11
132
0.83
0.18
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
11
132
0.83
0.18
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
11
132
0.83
0.18
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
11
132
0.83
0.18
1.4
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
58
1.21
0.18
1.1
1.5
—
—
—
0
0
(4035726)
17
195
0.86
0.18
1.4
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
5
67
0.74
0.17
2.0
1.7
—
0.0
—
0
14
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
69
0.72
0.17
1.8
1.7
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
8
73
1.10
0.16
1.1
1.1
—
8.3
—
0
14
(3019832) Treponema pallidum Ab [Presence] in Serum
40
375
1.08
0.13
1.6
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
52
493
1.07
0.13
1.5
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
17
189
0.89
0.12
1.2
1.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
10
115
0.86
0.11
1.4
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
12
106
1.14
0.10
1.1
3.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
20
184
1.09
0.09
1.8
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
57
1.05
0.08
1.8
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
31
293
1.07
0.08
1.5
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
10
89
1.13
0.07
1.6
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
37
355
1.05
0.06
3.3
2.9
ug/l
0.6
0.8
1.14
27
231
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
108
0.92
0.03
1.8
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
24
246
0.97
0.00
1.8
1.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
31
304
1.02
0.00
2.2
2.5
e6/l
3.5
3.0
0.13
17
162
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
11
108
1.02
0.00
1.6
1.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
14
138
1.02
0.00
1.4
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
19
193
0.98
0.00
1.8
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
28
277
1.01
0.00
1.5
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
17
166
1.03
0.00
1.4
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
76
0.92
0.00
1.7
1.8
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
11
110
1.00
0.00
1.3
1.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
8
82
0.97
0.00
4.9
3.8
mmol/l
25.5
23.9
—
8
75
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
224.8
—
0
6
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
7.8
—
0
5
(3029075) Extractable nuclear Ab panel - Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
8
0.00
0.00
0.0
1.0
—
151.4
—
0
8
(3013727) Leukocytes other/100 leukocytes in Blood
0
8
0.00
0.00
0.0
3.4
—
48.6
—
0
8
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
5
52
0.96
0.00
1.0
1.2
—
9.0
—
0
13
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
55
0.91
0.00
1.2
1.1
—
—
—
0
0
(4211845)
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
6
0.00
0.00
0.0
1.7
—
10.8
—
0
6
(3025577) Chromium [Mass/volume] in Blood
0
7
0.00
0.00
0.0
2.4
—
2.2
—
0
7
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
5
52
0.96
0.00
1.0
1.2
—
3.1
—
0
8
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.8
—
6.1
—
0
6
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
2.3
—
1.2
—
0
6
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
7
0.00
0.00
0.0
2.4
—
4.2
—
0
7
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
70
1.00
0.00
1.4
1.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_DIASTASIS and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_DIASTASIS | 0.982 [0.75, 1.28] | 0.891 |
| Birth year | 0.99 [0.98, 1.0] | 0.051 |
During the follow-up period (1.1.1998 — 31.12.2019), 73 out of 493 males with M13_DIASTASIS died.
Mortality risk
Mortality risk for people of age
years, who have M13_DIASTASIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.197% |
| 5 | No data | 1.252% |
| 10 | No data | 3.111% |
| 15 | No data | 5.867% |
| 20 | No data | 10.226% |
Relationships between endpoints
↥Index endpoint: M13_DIASTASIS – Diastasis of muscle
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data